Deep investigation opens unseen overpricing issues of Pharmaceutical firm
FDA may send overpricing notice to the Pharmaceutical firm. While investigating Saurya Pratap case against Medanta for overpricing, officers found the medicines used in the bill had MRP higher than…
Drug regulator plans national digital database of pharma manufacturers
NEW DELHI: India’s drug regulatory body is creating a national digital database of pharmaceutical manufacturers and their medicines so that regulators can be more effective when acting on problems like…
